Clinic
D & M Holdings LLC
D & M Holdings LLC was paid $1.01M by Medicaid between Jan 2018 and Feb 2024, across 12 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 56% of everything it billed.
33Billing provider infoD & M HOLDINGS LLC
SPOKANE, WA 99208
SPOKANE, WA 99208
33aNPI1821052325assigned 04/13/2006
33bProvider typeUrgent Care Clinic/Center
28Total paid$1.01M
24GClaims20,975
24DCodes billed12
24AFirst – last monthJan 2018 – Feb 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Washington
Rank by total paid#8 of 15
Median peer was paid$1.01M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,562 | $211K | |
| 2019 | 3,916 | $184K | |
| 2020 | 2,301 | $111K | |
| 2021 | 3,070 | $154K | |
| 2022 | 4,125 | $200K | |
| 2023 | 2,879 | $141K | |
| 2024incomplete | 122 | $6K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 56% | 10,935 | 10,275 | $565K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 39% | 8,081 | 7,936 | $389K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.7% | 538 | 518 | $17K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.3% | 168 | 167 | $13K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.1% | 332 | 329 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 123 | 121 | $5K |
| 80305 | <1% | 174 | 147 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 70 | 70 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 74 | 37 | $920.76 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 62 | 61 | $834.88 |
| 81003 | <1% | 405 | 392 | $622.93 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 13 | 12 | $20.08 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBIEBER, DAN (OWNER MANAGER)